Posts By Alex
818Wire StoriesVeristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 2021
Veristat Supported the NDA and Celebrates This Milestone Achievement for Children and Their Families Fighting This Rare Disease SOUTHBOROUGH, Mass.–(BUSINESS WIRE)–#rarediseaseday—Veristat, a...
- 807Wire Stories
Mainstay Medical Announces Commercial Launch of ReActiv8® in Australia
DUBLIN–(BUSINESS WIRE)–Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system...
- 796Wire Stories
Westwater Resources Announces Transfer to the NYSE American Stock Exchange
Ticker to Remain “WWR” CENTENNIAL, Colo.–(BUSINESS WIRE)–$WWR #NYSE—Westwater Resources, Inc. (“Westwater”) (NASDAQ: WWR), a battery graphite development company, announced today that it...
- 723Wire Stories
Eros Now Leverages Google Cloud for Artificial Intelligence Led Product Enhancements
AI Architecture to enable Subtitles Across Movies and Originals Content MUMBAI, India–(BUSINESS WIRE)–Eros STX Global Corporation (NYSE: ESGC) (“ErosSTX”), a global entertainment...
- 733Wire Stories
Muchen Launches Oclean Xpro, the Smart Electric Toothbrush
SHENZHEN, China–(BUSINESS WIRE)–At the dawn of this International Women’s Day, Muchen launches the smart electric toothbrush, Oclean Xpro. It has a powerful...
- 749Wire Stories
Criteria Acquires Australian-based Alcami Interactive, a Video Interviewing Platform
Leading assessment company dedicated to helping organizations make better talent decisions, responds to demand for video interviewing solutions LOS ANGELES–(BUSINESS WIRE)–#Criteria—Criteria, a...
- 828Wire Stories
Alteogen Announces Completion of Phase 1 Clinical Trial of Aflibercept Biosimilar in Wet AMD Patients
First clinical trial of Aflibercept biosimilar to be completed in Korea Supported by global formulation and process patents DAEJEON, South Korea–(BUSINESS...
- 1.1KWire Stories
Exelixis Enters into Exclusive License Agreement with WuXi Biologics to Support Further Expansion of its Growing Oncology Biologics Pipeline
– Exelixis has exclusive license to panel of monoclonal antibodies against an undisclosed oncology target for biologics applications, leveraging WuXi Biologics integrated...
- 907Wire Stories
Facedrive Partners with Plan International Canada to Combat Child Marriage in Bangladesh
For the rest of 2021, $1 from every Facedrive TraceSCAN device purchase will contribute to Plan International Canada’s campaign to raise $900,000...
- 939Wire Stories
In A First, Kerala Govt’s Global Meet Sets Model To Achieve Carbon Neutrality
THIRUVANANTHAPURAM, India–(BUSINESS WIRE)–#CarbonNeutralEvent–Conforming to the global sustainable development agenda, the second edition of the International Conference on Gender Equality (ICGE) organized by...
